
Thor Medical ASA
NANOV | OL
Overview
Corporate Details
- ISIN(s):
- NO0010597883 (+1 more)
- LEI:
- 5967007LIEEXZXG6DK30
- Country:
- Norway
- Address:
- Drammensveien 167, 0277 Oslo
- Website:
- https://www.thormedical.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
From rock to cancer drugs - Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The production process is based on a novel technology developed by Thor Medical that combines high efficiency and competitive cost structure with best in class environmental friendliness. All chemicals and radioactive materials are reprocessed and reused; therefore, the process produces very little waste. The process extracts only the radioactivity naturally occurring in thorium and therefore it requires no irradiation in nuclear reactors or high-cost accelerators. Since the source is thorium which decays with a half-life of 14 billion years we can produce continuously and provide a reliable supply of the sought-after alpha-particle emitters.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
![]() |
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
![]() |
Aptahem AB | Sweden | APTA | |
![]() |
Arctic Bioscience | Norway | ABS | |
![]() |
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
![]() |
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
![]() |
AroCell AB | Sweden | AROC | |
![]() |
Arterra Bioscience | Italy | ABS |